Drug Trial Radar · NCT00474240
AEGR-733 and Atorvastatin 20 mg vs. Monotherapy in Moderate Hypercholesterolemia
Last checked: Nov 20, 2026Latest source record: Mar 20, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
157
Actual
Start
Apr 2007
Primary completion
Oct 2008
Study completion Oct 2008
Sponsor
- Lead sponsor
- Aegerion Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 16, 2007
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to test the effectiveness of the study drug, AEGR-733 alone and in combination with the medication, atorvastatin (Lipitor), on cholesterol in volunteers with moderately high cholesterol.
Conditions
- Hypercholesterolemia
Interventions
Atorvastatin 20 mgDrug
AEGR-733 5 mgDrug
AEGR-733 10 mgDrug
PlaceboDrug
AEGR-733 5 mg + atorvastatin 20 mgDrug
AEGR-733 10 mg + atorvastatin 20 mgDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in LDL-C at 8 WeeksTime frame: Atfer 8 weeks on study drug
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Medical Affiliated Research Center
Huntsville, Alabama
Jacksonville Center for Clinical research
Jacksonville, Florida
Jacksonville Center For Clinical Research
Jacksonville, Florida
Renstar Medical Research
Ocala, Florida
North Georgia Clinical Research
Woodstock, Georgia
Radiant Research
Chicago, Illinois
Medsphere Medical Research Center
Evansville, Indiana
Midwest Institute for Clinical Research
Indianapolis, Indiana
Maine Research Associates
Auburn, Maine
Health Trends Research
Baltimore, Maryland
Piedmont Medical Research Associates
Winston-Salem, North Carolina
Sterling Research Group
Cincinnati, Ohio
Coastal Carolina Research Center
Goose Creek, South Carolina
Dallas Diabetes and Endocrine Center
Dallas, Texas
Diabetes and Glandular Disease Research
Dallas, Texas
Hampton Roads Center for Clinical Research
Norfolk, Virginia
National Clinical Research
Richmond, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.